v3.26.3
Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 17,443 $ 16,927 $ 56,362 $ 47,148
General and administrative 6,015 4,963 18,615 15,372
Total operating expenses 23,458 21,890 74,977 62,520
Loss from operations (23,458) (21,890) (74,977) (62,520)
Other income (expense):        
Interest income 2,116 2,900 6,318 8,733
Interest expense (4) (14) (18) (51)
Other expense (1) (31) (119) (111)
Total other income, net 2,111 2,855 6,181 8,571
Loss before income tax (21,347) (19,035) (68,796) (53,949)
Income tax expense 0 0 (77) (976)
Net loss (21,347) (19,035) (68,873) (54,925)
Other comprehensive (loss) income:        
Foreign currency translation adjustment 0 (26) 37 (84)
Comprehensive loss $ (21,347) $ (19,061) $ (68,836) $ (55,009)
Net loss per share, basic $ (1.08) $ (1.02) $ (3.6) $ (3.02)
Net loss per share, diluted $ (1.08) $ (1.02) $ (3.6) $ (3.02)
Weighted-average common shares outstanding, basic 19,704,164 18,712,767 19,146,768 18,189,185
Weighted-average common shares outstanding, diluted 19,704,164 18,712,767 19,146,768 18,189,185